[Congressional Record (Bound Edition), Volume 146 (2000), Part 16]
[Extensions of Remarks]
[Page 23865]
[From the U.S. Government Publishing Office, www.gpo.gov]



  IN HONOR OF DR. PAUL GREENGARD, 2000 NOBEL PRIZE WINNER IN MEDICINE

                                 ______
                                 

                        HON. CAROLYN B. MALONEY

                              of new york

                    in the house of representatives

                        Monday, October 23, 2000

  Mrs. MALONEY of New York. Mr. Speaker, I enthusiastically rise today 
to honor Dr. Paul Greengard, the 2000 Nobel Prize winner in medicine, 
who resides and teaches in my district. Dr. Greengard received the 
Nobel Prize for his discovery of how dopamine--a human neurotransmitter 
that controls one's movements, emotional responses, and ability to 
experience pleasure and pain--affects the central nervous system. His 
advancements in the field of neuroscience have greatly increased our 
understanding of the relationships between neurobiological chemicals 
and some of the world's most widespread neurological disorders, such as 
Parkinson's Disease, Alzheimer's Disease, and Schizophrenia. Such an 
achievement is one I hold in tremendous regard and I truly hope my 
colleagues recognize the importance of Dr. Greengard's groundbreaking 
discovery.
  Neurological diseases touch most every human being in some way. As 
the founder and Co-Chair of the Congressional Working Group on 
Parkinson's Disease, I am especially energized by Dr. Greengard's 
research. I sincerely hope that medical and academic professionals, 
buoyed by Dr. Greengard's achievements, continue their pursuit of 
uncovering the causes of the most pressing neurological disorders.
  Dr. Greengard is a genuinely fascinating individual. He currently 
serves as the head of the Laboratory of Molecular and Cellular 
Neuroscience at The Rockefeller University in New York City and is the 
director of the Zachary and Elizabeth M. Fisher Center for Research on 
Alzheimer's Disease, also at Rockefeller. The Fisher Center, where I 
serve as a member of the Board of Trustees alongside Fisher CEO Michael 
Stern, is an extraordinarily valuable research center where Dr. 
Greengard has made pioneering discoveries in neuroscience which provide 
a more conceptual understanding of how the nervous system functions at 
the molecular level. His research into the abnormalities associated 
with Dopamine serves as a window through which scientists can examine 
the effects that Dopamine has on psychiatric disorders of human beings, 
such as substance abuse and Attention Deficit Disorder.
  Dr. Greengard has dedicated his life to scientific exploration. Since 
1953, when he received his Ph.D. in biophysics from Johns Hopkins 
University, Dr. Greengard has worked as a scientific professional in 
every sense of the word. From his days as a scholar at Cambridge 
University in London, and years as a professor of pharmacology at Yale 
University, Dr. Greengard has possessed a passion for knowledge into 
the scientific basis of human existence. His life is nothing short of 
an admirable testament to the joy of scholarship and the rewards of 
knowledge.
  Mr. Speaker, I am immeasurably proud to have such an esteemed 
American living and working within my district. Dr. Greengard's Nobel 
Prize is a well-deserved honor and a tremendous reward for his 
dedication and tireless pursuit of scientific truth.

                          ____________________